News | Heart Valve Technology | April 22, 2019

New Consensus Document Explores Optimized Care for Valvular Heart Disease Patients

Document from five cardiovascular professional societies intended to increase identification of patients with VHD and emphasize best practices from 2014 and 2017 consensus documents

New Consensus Document Explores Optimized Care for Valvular Heart Disease Patients

April 22, 2019 — Five cardiovascular professional societies released a new consensus document on optimizing care for patients with valvular heart disease. The consensus document — produced by the American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), Society for Cardiovascular Angiography and Interventions (SCAI), and the Society of Thoracic Surgeons (STS) — is available online in the Journal of the American College of Cardiology (JACC).

The intent of this document is to propose a system of care for patients with valvular heart disease (VHD), the primary goal of which would be to optimize outcomes for all patients and ultimately improve the care of VHD at all centers. This approach is intended to increase the identification of patients with VHD and emphasize best practices as captured in the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease and the 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. It is also intended to promote the efficient utilization of resources, facilitate communication and continuity of care, and emphasize the need for transparency in reporting of and accountability for outcomes relative to national benchmarks.

For more information: www.acc.org


Related Content

News | Heart Valve Technology

Nov. 17, 2025 — Royal Philips has introduced DeviceGuide, an AI-powered device tracking* solution that assists ...

Home November 17, 2025
Home
News | Heart Valve Technology | Cedars-Sinai Medical Center

Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had ...

Home October 29, 2025
Home
News | Heart Valve Technology

Aug. 28, 2025 — Medtronic plc has announced it received U.S. Food and Drug Administration (FDA) approval for the ...

Home August 29, 2025
Home
News | Heart Valve Technology

Aug. 18, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home August 19, 2025
Home
News | Heart Valve Technology

Aug. 4, 2025 — Corcym announced that its Perceval Plus sutureless aortic heart valve was used in a first-ever robotic ...

Home August 05, 2025
Home
News | Heart Valve Technology

July 10, 2025 — On July 2, 2025, Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination ...

Home July 11, 2025
Home
News | Heart Valve Technology

June 27, 2025 – Foldax Inc., a leader in the development of innovative polymer heart valves, has announced compelling ...

Home June 27, 2025
Home
News | Heart Valve Technology

June 04, 2025 — HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough ...

Home June 12, 2025
Home
News | Heart Valve Technology

May 27, 2025 — Abbott has announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne ...

Home May 28, 2025
Home
News | Heart Valve Technology

May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the ...

Home May 02, 2025
Home
Subscribe Now